Dopamine induced neurodegeneration in a PINK1 model of Parkinson's disease

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Gandhi, Sonia ^a   Vaarmann, Annika ^a   Yao, Zhi ^a   Duchen, Michael R ^b   Wood, Nicholas W ^a   Abramov, Andrey Y ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN MITOCHONDRION; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CELL DEATH; CONTROLLED STUDY; DEPOLARIZATION; DISEASE MODEL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GENE; GENE MUTATION; KNOCKOUT MOUSE; MOUSE; NERVE CELL; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PINK1 GENE; RESPIRATORY CHAIN; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; CALCIUM; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINERGIC NEURONS; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, KNOCKOUT; MITOCHONDRIA; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; PARKINSON DISEASE; PROTEIN KINASES; REACTIVE OXYGEN SPECIES;

EID: 84861476741     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037564     Document Type: Article

References (22)

1. Burchell VS, Gandhi S, Deas E, Wood NW, Abramov AY, et al. (2010) Targeting mitochondrial dysfunction in neurodegenerative disease: Part I. Expert Opin Ther Targets. 10.1517/14728221003652489 [doi].
2. Deas E, Plun-Favreau H, Wood NW, (2009) PINK1 function in health and disease. EMBO Mol Med 1 152-165. 10.1002/emmm.200900024 [doi].
3. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MMK, Harvey K, et al. (2004) Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1. Science 304: 1158-1160.
4. Dagda RK, Cherra SJ, Kulich SM, Tandon A, Park D, et al. (2009) Loss of PINK1 Function Promotes Mitophagy through Effects on Oxidative Stress and Mitochondrial Fission. Journal of Biological Chemistry 284: 13843-13855.
5. Chu CT, (2010) Tickled PINK1: Mitochondrial homeostasis and autophagy in recessive Parkinsonism. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1802 20-28. doi DOI:10.1016/j.bbadis.2009.06.012.
6. Gandhi S, Wood-Kaczmar A, Yao Z, Plun-Favreau H, Deas E, et al. (2009) PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death. Mol Cell 33 627-638. S1097-2765(09)00129-4 [pii];10.1016/j.molcel.2009.02.013 [doi].
7. Vaarmann A, Gandhi S, Gourine AV, Abramov AY, (2010) Novel pathway for an old neurotransmitter: Dopamine-induced neuronal calcium signalling via receptor-independent mechanisms. Cell Calcium 48 176-182. S0143-4160(10)00124-7 [pii];10.1016/j.ceca.2010.08.008 [doi].
8. Vaarmann A, Gandhi S, Abramov AY, (2010) Dopamine induces Ca2+ signaling in astrocytes through reactive oxygen species generated by monoamine oxidase. J Biol Chem 285 25018-25023. M110.111450 [pii];10.1074/jbc.M110.111450 [doi].
9. Abramov AY, Smulders-Srinivasan TK, Kirby DM, Acin-Perez R, Enriquez JA, et al. (2010) Mechanism of neurodegeneration of neurons with mitochondrial DNA mutations. Brain 133 797-807. awq015 [pii];10.1093/brain/awq015 [doi].
10. Yao Z, Gandhi S, Burchell VS, Plun-Favreau H, Wood NW, et al. (2011) Cell metabolism affects selective vulnerability in PINK1-associated Parkinson's disease. J Cell Sci 124 4194-4202. jcs.088260 [pii];10.1242/jcs.088260 [doi].
11. Youdim MB, Bakhle YS, (2006) Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness. Br J Pharmacol 147 Suppl 1 S287-S296. 0706464 [pii];10.1038/sj.bjp.0706464 [doi].
12. Das UN, (2006) Is pyruvate an endogenous anti-inflammatory molecule? Nutrition 22 965-972. doi DOI:10.1016/j.nut.2006.05.009.
13. Chan CS, Gertler TS, Surmeier DJ, (2009) Calcium homeostasis, selective vulnerability and Parkinson's disease. Trends in Neurosciences 32 249-256. doi DOI:10.1016/j.tins.2009.01.006.
14. Chan CS, Guzman JN, Ilijic E, Mercer JN, Rick C, et al. (2007)/'Rejuvenation/' protects neurons in mouse models of Parkinson/'s disease. Nature 447: 1081-1086 10.1038/nature05865.
15. Mosharov EV, Larsen KE, Kanter E, Phillips KA, Wilson K, et al. (2009) Interplay between Cytosolic Dopamine, Calcium, and [alpha]-Synuclein Causes Selective Death of Substantia Nigra Neurons. Neuron 62 218-229. doi DOI:10.1016/j.neuron.2009.01.033.
16. Rasola A, Bernardi P, (2007) The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis. Apoptosis 12: 815-833 10.1007/s10495-007-0723-y.
17. Abramov AY, Fraley C, Diao CT, Winkfein R, Colicos MA, et al. (2007) Targeted polyphosphatase expression alters mitochondrial metabolism and inhibits calcium-dependent cell death. Proceedings of the National Academy of Sciences 104: 18091-18096.
18. Basso E, Petronilli V, Forte MA, Bernardi P, (2008) Phosphate Is Essential for Inhibition of the Mitochondrial Permeability Transition Pore by Cyclosporin A and by Cyclophilin D Ablation. Journal of Biological Chemistry 283: 26307-26311.
19. Macleod GT, Marin L, Charlton MP, Atwood HL, (2004) Synaptic Vesicles: Test for a Role in Presynaptic Calcium Regulation. J Neurosci 24: 2496-2505.
20. Szabadkai G, Rizzuto R, (2007) Chaperones as Parts of Organelle Networks. In pp. 64-77.
21. Bernardi P, (1992) Modulation of the mitochondrial cyclosporin A-sensitive permeability transition pore by the proton electrochemical gradient. Evidence that the pore can be opened by membrane depolarization. Journal of Biological Chemistry 267: 8834-8839.
22. Chaudhuri KR, Schapira AH, (2009) Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. The Lancet Neurology 8 464-474. doi DOI:10.1016/S1474-4422(09)70068-7.